VERISMO Study: An Observational study of Ocrelizumab Treated Patients with Multiple Sclerosis (MS) to Determine the Incidence and Mortality Rates of Breast Cancer and all Malignancies

Summary

The purpose of this study is to obtain additional safety information on OCREVUS® and to gain insights about how well OCREVUS® is tolerated by patients to whom it is prescribed in routine practice.

Contact us

To learn more about clinical trials at ProHealth Care, email research.institute@phci.org or call 262-928-3447.

Quick Access Links